altb-268
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 17, 2023 (NCT05723692)
Timeline
Indications
Mechanism of action
SELPLG agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06109441 | Phase 2 | Dec 4, 2023 | AltruBio |
| NCT05723692 | Phase 1 | Jan 17, 2023 | AltruBio, ICON |
Showing 2 of 2 trials
Page 1 / 1